Can mycophenolate (Cellcept) cause a malar rash?

Mycophenolate Mofetil and Malar Rash

Mycophenolate mofetil (MMF) does not typically cause malar rash, but it can occasionally be associated with drug-induced subacute cutaneous lupus erythematosus (DI-SCLE) which may present with malar rash as one of its manifestations.

Drug-Induced Lupus Manifestations

While MMF is actually used to treat systemic lupus erythematosus (SLE) and its manifestations including lupus nephritis 1, 2, it has been associated with certain dermatological side effects:

• MMF can cause various skin reactions, though malar rash is not listed among its common adverse effects 3
• Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE) has been reported with various medications and can present with malar rash in 45% of cases 4
• The British Journal of Dermatology study found that malar rash occurred significantly more frequently in drug-induced SCLE than in idiopathic SCLE (45% vs 6%) 4

Common Dermatological Side Effects of MMF

MMF is more commonly associated with other skin manifestations:

• Acne-like eruptions have been reported in SLE patients taking MMF 5
• These acne-like lesions may present as papulo-pustular and nodular skin lesions, sometimes with unusual features 5
• In some cases, these lesions were found to be associated with Staphylococcus aureus infections 5

MMF in SLE Treatment

It's important to note that MMF is actually a treatment for SLE rather than a cause of malar rash:

• MMF is recommended by the American College of Rheumatology for treatment of lupus nephritis 2
• It's used as both induction and maintenance therapy for lupus nephritis 2
• MMF has shown effectiveness in treating SLE patients who were inadequately controlled with corticosteroids, antimalarials, and other immunosuppressives 6, 7

Differential Diagnosis for Malar Rash in Patients on MMF

If a patient on MMF develops a malar rash, consider:

1. Disease flare of underlying SLE (most common)
2. Drug-induced SCLE (less common)
3. Photosensitivity reaction (MMF can increase photosensitivity)
4. Other medication effects (if patient is on multiple medications)

Management Approach

If malar rash develops in a patient taking MMF:

1. Evaluate for signs of SLE disease activity using clinical signs and laboratory tests (anti-dsDNA, complement levels) 1
2. Consider topical treatments for the rash:
   • Topical tacrolimus has shown efficacy in treating malar rash of SLE 8
   • Topical corticosteroids may be used for short periods
3. Ensure adequate photoprotection as MMF can increase photosensitivity 3
4. If the rash is suspected to be drug-induced and severe:
   • Consider temporary discontinuation of MMF
   • Consult with rheumatology before making medication changes in SLE patients

Key Takeaway

Malar rash is not a common direct side effect of MMF. In fact, MMF is often used to treat SLE manifestations including skin involvement. If a patient on MMF develops a malar rash, it's more likely to represent a flare of underlying SLE or possibly a rare drug-induced lupus-like syndrome rather than a direct effect of the medication.